Markus Leo

512 total citations
20 papers, 390 citations indexed

About

Markus Leo is a scholar working on Molecular Biology, Genetics and Physiology. According to data from OpenAlex, Markus Leo has authored 20 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Genetics and 8 papers in Physiology. Recurrent topics in Markus Leo's work include Pain Mechanisms and Treatments (7 papers), Neurogenetic and Muscular Disorders Research (7 papers) and Cancer Treatment and Pharmacology (6 papers). Markus Leo is often cited by papers focused on Pain Mechanisms and Treatments (7 papers), Neurogenetic and Muscular Disorders Research (7 papers) and Cancer Treatment and Pharmacology (6 papers). Markus Leo collaborates with scholars based in Germany, Canada and Netherlands. Markus Leo's co-authors include Tim Hagenacker, Christoph Kleinschnitz, Maria Schäfers, Jürgen Thomale, Christine Gottschling, Rebecca Conrad, Andréas Faissner, Stefan Wiese, Teresa Tsai and Marvin K. Schulte and has published in prestigious journals such as International Journal of Molecular Sciences, Nature Chemical Biology and Experimental Neurology.

In The Last Decade

Markus Leo

18 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus Leo Germany 12 151 110 96 77 46 20 390
Travis P. Barr United States 10 252 1.7× 177 1.6× 15 0.2× 115 1.5× 22 0.5× 14 590
Andrea Link Germany 10 226 1.5× 258 2.3× 99 1.0× 217 2.8× 17 0.4× 15 698
П. А. Абушик Russia 13 197 1.3× 270 2.5× 22 0.2× 191 2.5× 58 1.3× 23 678
Ethel Derr‐Yellin United States 13 68 0.5× 287 2.6× 74 0.8× 168 2.2× 29 0.6× 23 798
Silvia Squillace United States 9 154 1.0× 139 1.3× 35 0.4× 75 1.0× 7 0.2× 11 352
Dexuan Ma China 13 85 0.6× 208 1.9× 39 0.4× 99 1.3× 19 0.4× 21 526
Natalia Kołosowska Finland 11 182 1.2× 117 1.1× 20 0.2× 107 1.4× 10 0.2× 11 537
Nobuo Takasu Japan 13 69 0.5× 265 2.4× 101 1.1× 106 1.4× 18 0.4× 33 621
Xiaotong Tang China 12 43 0.3× 193 1.8× 48 0.5× 82 1.1× 23 0.5× 21 460
Zhifu Wang China 14 68 0.5× 221 2.0× 42 0.4× 111 1.4× 28 0.6× 26 460

Countries citing papers authored by Markus Leo

Since Specialization
Citations

This map shows the geographic impact of Markus Leo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Leo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Leo more than expected).

Fields of papers citing papers by Markus Leo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Leo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Leo. The network helps show where Markus Leo may publish in the future.

Co-authorship network of co-authors of Markus Leo

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Leo. A scholar is included among the top collaborators of Markus Leo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Leo. Markus Leo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ullrich, Daniel, Dagmar Führer, Heike Heuer, et al.. (2025). Triiodothyronine treatment in mice improves stroke outcome and reduces blood–brain barrier damage. European Thyroid Journal. 14(1).
2.
3.
Roos, Andreas, Andreas Hentschel, Adela Della Marina, et al.. (2024). Thrombospondin-4 as potential cerebrospinal fluid biomarker for therapy response in pediatric spinal muscular atrophy. Journal of Neurology. 271(10). 7000–7011. 3 indexed citations
4.
Roos, Andreas, Andreas Hentschel, Nancy Meyer, et al.. (2024). Alteration of LARGE1 abundance in patients and a mouse model of 5q-associated spinal muscular atrophy. Acta Neuropathologica. 147(1). 53–53. 6 indexed citations
5.
Leo, Markus, Fabian Mairinger, Andreas Roos, et al.. (2023). Analysis of Free Circulating Messenger Ribonucleic Acids in Serum Samples from Late-Onset Spinal Muscular Atrophy Patients Using nCounter NanoString Technology. Cells. 12(19). 2374–2374. 3 indexed citations
6.
Roos, Andreas, et al.. (2023). Spinal astrocyte dysfunction drives motor neuron loss in late-onset spinal muscular atrophy. Acta Neuropathologica. 145(5). 611–635. 7 indexed citations
7.
Stolte, Benjamin, Olivia Schreiber‐Katz, René Günther, et al.. (2022). Prevalence of Anti-Adeno-Associated Virus Serotype 9 Antibodies in Adult Patients with Spinal Muscular Atrophy. Human Gene Therapy. 33(17-18). 968–976. 11 indexed citations
8.
9.
Leo, Markus, et al.. (2021). Cisplatin-induced activation and functional modulation of satellite glial cells lead to cytokine-mediated modulation of sensory neuron excitability. Experimental Neurology. 341. 113695–113695. 29 indexed citations
10.
Leo, Markus, et al.. (2021). Modulation of Glutamate Transporter EAAT1 and Inward-Rectifier Potassium Channel Kir4.1 Expression in Cultured Spinal Cord Astrocytes by Platinum-Based Chemotherapeutics. International Journal of Molecular Sciences. 22(12). 6300–6300. 8 indexed citations
11.
Sánchez-Mendoza, Eduardo H., Luiza Martins Nascentes Melo, Egor Dzyubenko, et al.. (2020). Compromised Hippocampal Neuroplasticity in the Interferon-α and Toll-like Receptor-3 Activation-Induced Mouse Depression Model. Molecular Neurobiology. 57(7). 3171–3182. 15 indexed citations
12.
Leo, Markus, et al.. (2020). Activation and functional modulation of satellite glial cells by oxaliplatin lead to hyperexcitability of sensory neurons in vitro. Molecular and Cellular Neuroscience. 105. 103499–103499. 29 indexed citations
13.
Leo, Markus, et al.. (2020). Platinum-Based Drugs Cause Mitochondrial Dysfunction in Cultured Dorsal Root Ganglion Neurons. International Journal of Molecular Sciences. 21(22). 8636–8636. 28 indexed citations
14.
Weiss, Linda C., Bauke Albada, Sven W. Meckelmann, et al.. (2018). Identification of Chaoborus kairomone chemicals that induce defences in Daphnia. Nature Chemical Biology. 14(12). 1133–1139. 47 indexed citations
15.
Leo, Markus, et al.. (2018). Oxaliplatin Modulates the Characteristics of Voltage-Gated Calcium Channels and Action Potentials in Small Dorsal Root Ganglion Neurons of Rats. Molecular Neurobiology. 55(12). 8842–8855. 25 indexed citations
16.
Leo, Markus, et al.. (2017). Cisplatin alters the function and expression of N-type voltage-gated calcium channels in the absence of morphological damage of sensory neurons. Molecular Pain. 13. 2223550341–2223550341. 16 indexed citations
17.
Leo, Markus, et al.. (2017). Intrathecal Resiniferatoxin Modulates TRPV1 in DRG Neurons and Reduces TNF-Induced Pain-Related Behavior. Mediators of Inflammation. 2017. 1–8. 27 indexed citations
18.
Leo, Markus, et al.. (2016). Cisplatin-induced neuropathic pain is mediated by upregulation of N-type voltage-gated calcium channels in dorsal root ganglion neurons. Experimental Neurology. 288. 62–74. 47 indexed citations
19.
Leo, Markus, et al.. (2015). Modulation of Voltage‐Gated Sodium Channels by Activation of Tumor Necrosis Factor Receptor‐1 and Receptor‐2 in Small DRG Neurons of Rats. Mediators of Inflammation. 2015(1). 124942–124942. 47 indexed citations
20.
Tsai, Teresa, Rebecca Conrad, Christine Gottschling, et al.. (2013). 7,8-Dihydroxyflavone leads to survival of cultured embryonic motoneurons by activating intracellular signaling pathways. Molecular and Cellular Neuroscience. 56. 18–28. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Travis P. Barr Breakdown of academic impact, for papers by Andrea Link Breakdown of academic impact, for papers by П. А. Абушик Breakdown of academic impact, for papers by Ethel Derr‐Yellin Breakdown of academic impact, for papers by Silvia Squillace Breakdown of academic impact, for papers by Dexuan Ma Breakdown of academic impact, for papers by Natalia Kołosowska Breakdown of academic impact, for papers by Nobuo Takasu Breakdown of academic impact, for papers by Xiaotong Tang Breakdown of academic impact, for papers by Zhifu Wang
Rankless by CCL
2026